Twitter Facebook LinkedIn YouTube

THC BioMed (CSE:THC) delivered its first shipment of cannabis to the province of British Columbia

Video Platform Video Management Video Solutions Video Player

The company’s high-grade Landrace strains have been selected for the recreational market and will initially be available in British Columbia and Ontario with pending supply agreements with a Saskatoon retailer.

Additional Information:

Company: THC BioMed Intl
Website: http://www.THCbiomed.com
Stock Symbol: CSE: THC
Date Published: Oct 2, 2018
Transcript: Available

Video Transcript:

I’m Megan Edwards for Investmentpitch Media

THC BioMed Intl has delivered its first shipment of cannabis to the province of British Columbia, marking a significant and fundamental change in the company’s business operations.

The company’s high-grade Landrace strains have been selected for the recreational market and will initially be available in British Columbia and Ontario with pending supply agreements with a Saskatoon retailer.

The company is actively working towards ensuring its products will be available to all adult recreational users in all provinces.

THC Biomed will initially supply THC Sativa, THC Indica, THC Hybrid and THC/CBD Landrace strains.

These varieties will be available in Dried Bud, Cannabis oil and pre-rolled joints.

Management promises products that will be effective and deliver the desired experience without the debilitating side effects commonly associated with cannabis, offering recreational adult users a product that is potent and consistent in its quality and effects.

The company is also working on having its cannabis beverage “THC Kiss” approved for release.

Although production and sale of beverages is not currently legal in Canada, it is expected that beverages will become legal at a later date.

John Miller, CEO, stated: “THC has conducted extensive research on cannabis edibles and beverages and I have found our product to be exclusive in its category. We are thrilled to have formulated a cannabis beverage that is purely organic, works in a recreational setting and can offer even the most seasoned consumers an entirely new and invigorating experience.”

Located in Kelowna, British Columbia, THC, a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations, also produces and sells dried and fresh marijuana and cannabis oil for medical purposes.

THC is a leader in scientific research and the development of products and services related to the medical cannabis industry, and company management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

THC BioMed is included in the Horizons Marijuana Life Sciences Index ETF, the first and world’s largest ETF offering direct exposure to North America’s top marijuana bioengineering and production companies.

The shares are trading at $0.81.

For more information, please visit www.THCbiomed.com, contact John Miller, President & CEO, at 1-844-THCMEDS or email info@THCbiomed.com.

I’m Megan Edwards for Investmentpitch Media